Purpose: To model and interpret drug distribution in the dermis and underlying tissues after topical application which is relevant to the treatment of local conditions. Methods: We created a new physiological pharmacokinetic model to describe the effect of blood flow, blood protein binding and dermal binding on the rate and depth of penetration of topical drugs into the underlying skin.
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Introduction
Drugs and other solutes are frequently applied to the skin for a range of purposes including the treatment of local dermatological disorders, systemic delivery (eg nicotine, nitroglycerin, fentanyl patches), supportive treatment of local muscle injuries, cosmetic, UV protection and insect repellents. This interest in topical applications of pharmaceutical and cosmetic products generated significant research effort into measurement, modelling and prediction of the rate of solutes penetration through the skin. The research effort into understanding the distribution of topically applied solutes in underlying tissues was relatively modest, confounded by inability to recreate invivo conditions using in-vitro experiments (1) and the invasiveness associated with the collection of such data using biopsy. Most prominent in this regard is the work of Schaefer and colleagues who obtained human tissue concentration-depth profiles of various drugs in-vivo after topical application (1-5).
As studies on skin solute concentration-tissue depths profiles after topical application in man are, in general, limited due to the invasiveness associated with the collection of such data, mathematical modelling and prediction of concentration-depths profiles for different drugs is of importance in dermatology. Singh and Roberts (6, 7) have used compartmental pharmacokinetic model assuming first-order diffusional mass transfer between the dermis and underlying tissues compartments with its concurrent elimination due to blood flow to model salicylic acid distribution in rat after topical application. Later Gupta et al (8) successfully modelled spatial distribution of 2',3'-dideoxyinosine in the dermis of a rat using a distributed elimination model. Cross & Roberts (9) used a tissue diffusion-dermal blood flow clearance model similar to the model of Gupta et al (8) but taking into account declining concentration in the donor phase to describe drug distribution kinetics in wound tissue after topical application. Recently, the data of Singh and Roberts (7) was reanalysed with a similar distributed diffusion-clearance model by Kretsos et al (10) and found to be consistent with this model. Kretsos and Kasting (11) also developed a new model to describe the dermal capillary clearance process based on assumed periodic microscopic distribution of dermal capillaries in three dimensional space. This model yields localised concentration in the dermis, but so far only applies to the steady state case.
In this work, we developed a new model that takes into account transport to deeper tissues by blood and/or lymphatics. The model also includes the potential contribution to transport processes by dermal diffusion and vascular wall permeability. We use a combination of human biopsy data generated by Schaefer and colleagues (1-5) and our own human in-vitro dermis penetration experiments to obtain two critically important parameters of the distributed model: dermis diffusion/dispersion coefficient and dermal blood clearance rate for six solutes -Desoximetasone (Des), Econazole (Ec), Hydrocortisone (Hyd), 8-Methoxypsoralen (Met), Retinoic acid (RA), Triamcinolone acetonide (TA) (molecular weight, solubility and other physicochemical properties of this solutes are presented in Table 1 ).
Theory

In vivo dermal distribution model
The distributed elimination model (8, 9, 12) is often used to describe dermis concentration-depth profiles and is similar to the model previously introduced for peritoneum by Dedrick et al. (13) .
These previous studies have assumed all solute transport to deeper layers occurs by molecular diffusion. The distributed elimination model defines concentration in the dermis by the diffusion equation with elimination:
where C d (x,t) is the concentration of the solute in the layer of the dermis at depth x at time t, D is the effective molecular diffusion coefficient in the dermis and k e is an assumed elimination rate from the dermis. An alternative to the molecular diffusion of the solute is that D is a dispersion term used widely in chemical engineering (14) and in organ pharmacokinetics (15) and defines transport by both blood and diffusion in the dermis. Partitioning of solute into blood capillaries of the dermis and its subsequent convective transport and partitioning back into the tissue could also significantly contribute to the spatial transport of the solute. Blood in the tissue capillaries can flow in all possible directions, it can be argued that this repartitioning and convective transport of the solute will be similar to a random walk process. The lymphatic flow could also be a contributing factor to the solute tissue transport. In order to recognise these facts D in equation 1 needs to be replaced by D t :
where D v is the contribution to the transport from blood and/or lymphatics. If the repartitioning and convective transport or lymphatic transport do contribute significantly to the transport of solute, D v will be much greater than molecular diffusion coefficient (D). If the transport is dominated by molecular diffusion, then D t ≈ D. For the solute that is bound in the dermis, and only unbound solute is diffusing, the effective diffusion coefficient is defined as:
where D u is the diffusion rate of unbound solute.
In equation 1, it is implicitly assumed that the elimination rate (k e ) is due to blood flow clearance, but hitherto no connections to physiological parameters made it difficult to analyse physiological meaning of this parameter. In order to relate this elimination rate to such physiological parameters as blood flow in the dermis and permeability surface area of blood capillaries in the dermis we consider a simple two compartmental approach to diffusion/dispersion in the dermis and elimination by blood flow in the small volume of the dermis (V d ) at depth x (see Fig 1) . Equations which describe the diffusion/dispersion in the dermis compartment and partitioning into the adjacent blood compartment with subsequent elimination are:
where V b is the blood volume adjacent to the dermis, Q b is the blood flow rate in the volume V d , and PS is the permeability surface area product (PS, sometimes abbreviated as PA) which is standard term in pharmacokinetics that consists of the permeability coefficient (P) often used to It is important to emphasise that equations 4 and 5 do not take into account the complex physiology of blood circulation in the skin (see Fig 1A) . 
Hence, at steady state, the form of the derived two compartmental dermal distribution model is identical with the distributed elimination model (equation 1), except that the elimination rate can now be defined in terms of physiological parameters as follows:
Kretsos et al (12) arrived at a similar expression for k e but did not recognise the effect that solute binding may have on the elimination rate.
It follows from equation 10 that when penetration of the solute into the blood capillary is the rate limiting process, that is fu b ps << q b , k e will be determined by ps so that equation 10 simplifies to k e being dependent on permeability surface area for blood capillaries ps:
On the other hand, when blood flow q b is rate limiting, (fu b ps >> q b ), so that now equation 10 simplifies to k e being dependent on tissue blood flow qb:
Solving equation 9 with boundary conditions 6 and 7 yields the concentration of solute in the dermis for the steady state:
We note that equation 13 can also be obtained by taking a limit where derm ρ is the density of the dermis assumed to be 1g/ml. Using eqs (16-18) diffusion coefficient was determined from both k p and t lag . We note that factor 2 in (18) 
Results
In Fig 2, acid, and therefore their effective solubility in the buffer at pH=7.4 will be higher than that in water, especially for the acid RA.
It can be seen from Table 1 that the solubility in plasma for all solutes with the exception of Ec is higher but close to that in the receptor phase, which is consistent with receptor phase bovine serum albumin concentration being similar to that of blood. The much higher solubility in plasma and blood for Ec is probably due to its strong binding to some proteins other than albumin (which is present in the receptor phase).
Dermal partition, permeability and diffusion coefficients are derived from our in vitro dermal penetration studies and presented in Table 2 . It should be noted that K m is the partitioning coefficient between dermis and the donor solution that contains 4% bovine serum albumin and that this partitioning coefficient can differ from K dermis/water , especially for strongly protein bound solutes. Diffusion coefficients were derived from both lag time and permeability coefficient and were found to be similar with the exception of Met, for which there is about a factor of two difference between the two values. The fraction unbound in the dermis and blood were estimated as the ratio of solubility in the water at pH=7.4 ( Table 2 ), but not reduce its mobility/diffusion coefficient to the extent predicted by equation 3, as this equation assumes that only unbound solute is diffusing.
In Fig 2, it was assumed that the steady state was achieved at the time of data collection. This will only be true, if D t is large enough. In previous studies (8) to assume that the dermal transport to deeper layers is faster than molecular diffusion alone and therefore D t >>D. The assumption of fast dispersion transport leads to the conclusion that the solutes reach the steady state relatively early (before 100 minutes) and indeed, as discussed above, provides satisfactory fits for most solutes (Fig 2) .
In Figs 5A and 5B the data for parameter k d (Table 2 ) was analysed using equation 14, where it was assumed that permeability-surface area per unit volume of dermis is proportional to the octanol/water partitioning, that is ps=A×10 logP =A×P, where A is a fitting parameter. In Fig 5A another fitting parameter was q b , while D t was fixed to the molecular diffusion coefficient. It can be seen that the quality of regression is very poor, confirming the conclusion of the above analysis that transport cannot be explained by molecular diffusion alone. In Fig 5B similar regression was performed, but D t was given a chance to be higher, corresponding to D t determined by blood/lymphatic transport, or equal to diffusion coefficient. In order to reduce the number of fitting parameters it was assumed that the dispersion coefficient is the same for all solutes. 
Discussion
This work shows that, for the compounds studied here in human dermis in vivo, the transport of the compounds into deeper tissues after topical application must involve transport into those tissues via the blood and/or lymphatics as well as by diffusion and that this transport cannot be described by dermal diffusion alone. In order for convective blood flow transport to make a significant contribution to transport to deeper tissues, there must be sufficient binding to plasma proteins and blood flow as the surface area of blood vessels is much less than that for the dermal matrix through which diffusion transport will occur. Hence, the contribution of dermal blood flow transport is likely to be markedly reduced when there is vasoconstriction. Others have previously assumed that only molecular diffusion in the dermis have contributed to penetration to deeper layers of dermis, suggests that transport occurs mostly by blood/lymphatic flow rather than molecular diffusion explaining the transport of solutes to deeper tissues, as assumed previously. (8) (9) (10) We note that the model, as formulated in this work, is somewhat a simplification of the physiological dermal transport and clearance. Most significantly it was assumed that the blood flow rate per unit volume of dermis (q b ) is a constant parameter. Recent work on spatial distribution of dermal circulation (22) suggests that q b decreases quasi-exponentially to a certain depth and is site and skin condition dependent. As this spatial dependence will prohibit the simple analysis of data with our model, it was considered beyond the scope of this paper. It has to be noted that this simplification will not affect the main conclusion of this paper that transport to deeper tissues is not by diffusion alone, as blood flow rate (q b ) only contributes to clearance (k e ) but not to diffusion coefficient (D). Further simplification is that, similar to the modelling of liver clearance (15), dispersion was assumed to be a constant parameter independent of other physiological parameters of the model. We have also previously related the dispersion coefficient used to describe liver elimination and transport directly to the morphology of the system and physiologically related parameters (23). The model described here for dermal transport and clearance could, in due course, be further developed in more precisely to be related to the detailed morphology and physiology of this dermal dispersion is indicative also of the axial lymphatic transport to deeper tissues, it is more than a factor of two higher than the fastest dermal diffusion coefficient measured in this work (D = 4.3×10 -7 cm 2 s -1 for hydrocortisone, see Table 2 ). Such a difference in dispersion would be consistent with a lower variation in dermal blood flows and vessel dimensions than found for lymphatic vessels.
In this work, we have limited our analysis of dermal distribution to data obtained from human experiments after a topical application to solute concentration profiles in the dermis obtained from skin biopsy. We felt that biopsy represents a "gold standard" in measuring dermal distribution of solutes. Human dermal distribution data is also available from microdialysis experiments and we have analysed this data separately, with similar findings. The nature of cutaneous microdialysis is such that there are additional substantial experimental and data interpretation considerations are beyond the scope and the focus of this paper. Hence, we are seeking to analyse this in a separate paper. A limitation of the present analysis is the assumption of no contribution of topically absorbed drug into the systemic circulation contributing to the underlying tissue concentrations on recirculation. Our previous work has suggested that this only occurs at long times and then with most substantial contribution to tissue concentrations deep below the applied site (25), relative to the superficial tissues close to the topical application site, as studied here.
Conclusions
In this work, dermal disposition of solutes after topical application was investigated. A new two compartment dermal clearance model that includes both transport by dermal blood vessels and by dermal diffusion was introduced to better relate dermal transport to the known dermal morphology and physiology in vivo. A key outcome of our analysis is that the molecular diffusion of solutes in the dermis is insufficient to alone explain solute transport to the deeper layers of dermis in vivo.
When the contribution of dermal transport to the deeper layers due to blood or lymphatic transport is included, consistency is obtained between observed and previously described in vivo literature data. Tables   Table 1. Physicochemical properties of solutes   Table 2 . Solute model parameters for transport in the dermis
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